Publication: Long runs of homozygosity are associated with Alzheimer's disease.
| dc.contributor.author | Moreno-Grau, Sonia | |
| dc.contributor.author | Fernández, Maria Victoria | |
| dc.contributor.author | de Rojas, Itziar | |
| dc.contributor.author | García-González, Pablo | |
| dc.contributor.author | Hernández, Isabel | |
| dc.contributor.author | Farias, Fabiana | |
| dc.contributor.author | Budde, John P | |
| dc.contributor.author | Quintela, Inés | |
| dc.contributor.author | Madrid, Laura | |
| dc.contributor.author | González-Pérez, Antonio | |
| dc.contributor.author | Montrreal, Laura | |
| dc.contributor.author | Alarcón-Martín, Emilio | |
| dc.contributor.author | Alegret, Montserrat | |
| dc.contributor.author | Maroñas, Olalla | |
| dc.contributor.author | Pineda, Juan Antonio | |
| dc.contributor.author | Macías, Juan | |
| dc.contributor.author | Marquié, Marta | |
| dc.contributor.author | Valero, Sergi | |
| dc.contributor.author | Benaque, Alba | |
| dc.contributor.author | Clarimón, Jordi | |
| dc.contributor.author | Bullido, María Jesús | |
| dc.contributor.author | Garcia-Ribas, Guillermo | |
| dc.contributor.author | Pástor, Pau | |
| dc.contributor.author | Sánchez-Juan, Pascual | |
| dc.contributor.author | Álvarez, Victoria | |
| dc.contributor.author | Piñol-Ripoll, Gerard | |
| dc.contributor.author | García-Alberca, Jose María | |
| dc.contributor.author | Royo, José Luis | |
| dc.contributor.author | Franco-Macías, Emilio | |
| dc.contributor.author | Mir, Pablo | |
| dc.contributor.author | Calero, Miguel | |
| dc.contributor.author | Medina, Miguel | |
| dc.contributor.author | Rábano, Alberto | |
| dc.contributor.author | Ávila, Jesús | |
| dc.contributor.author | Antúnez, Carmen | |
| dc.contributor.author | Real, Luis Miguel | |
| dc.contributor.author | Orellana, Adelina | |
| dc.contributor.author | Carracedo, Ángel | |
| dc.contributor.author | Sáez, María Eugenia | |
| dc.contributor.author | Tárraga, Lluís | |
| dc.contributor.author | Boada, Mercè | |
| dc.contributor.author | Cruchaga, Carlos | |
| dc.contributor.author | Ruiz, Agustín | |
| dc.contributor.funder | National Institutes of Health (Estados Unidos) | |
| dc.contributor.funder | Alzheimer's Association | |
| dc.contributor.funder | Fundación La Caixa | |
| dc.contributor.funder | Instituto de Salud Carlos III | |
| dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | |
| dc.contributor.funder | Ministerio de Sanidad (España) | |
| dc.contributor.funder | Alzheimer’s Disease Neuroimaging Initiative | |
| dc.contributor.funder | NIH - National Institute on Aging (NIA) (Estados Unidos) | |
| dc.contributor.funder | NIH - National Institute of Biomedical Imaging and Bioengineering (NIBIB) (Estados Unidos) | |
| dc.date.accessioned | 2021-04-19T15:21:17Z | |
| dc.date.available | 2021-04-19T15:21:17Z | |
| dc.date.issued | 2021-02-24 | |
| dc.description.abstract | Long runs of homozygosity (ROH) are contiguous stretches of homozygous genotypes, which are a footprint of inbreeding and recessive inheritance. The presence of recessive loci is suggested for Alzheimer's disease (AD); however, their search has been poorly assessed to date. To investigate homozygosity in AD, here we performed a fine-scale ROH analysis using 10 independent cohorts of European ancestry (11,919 AD cases and 9181 controls.) We detected an increase of homozygosity in AD cases compared to controls [βAVROH (CI 95%) = 0.070 (0.037-0.104); P = 3.91 × 10-5; βFROH (CI95%) = 0.043 (0.009-0.076); P = 0.013]. ROHs increasing the risk of AD (OR > 1) were significantly overrepresented compared to ROHs increasing protection (p < 2.20 × 10-16). A significant ROH association with AD risk was detected upstream the HS3ST1 locus (chr4:11,189,482‒11,305,456), (β (CI 95%) = 1.09 (0.48 ‒ 1.48), p value = 9.03 × 10-4), previously related to AD. Next, to search for recessive candidate variants in ROHs, we constructed a homozygosity map of inbred AD cases extracted from an outbred population and explored ROH regions in whole-exome sequencing data (N = 1449). We detected a candidate marker, rs117458494, mapped in the SPON1 locus, which has been previously associated with amyloid metabolism. Here, we provide a research framework to look for recessive variants in AD using outbred populations. Our results showed that AD cases have enriched homozygosity, suggesting that recessive effects may explain a proportion of AD heritability. | es_ES |
| dc.description.peerreviewed | Sí | es_ES |
| dc.description.sponsorship | The Genome Research at Fundació ACE project (GR@ACE) is supported by Fundación bancaria “La Caixa,” Grifols SA, Fundació ACE, and ISCIII (Ministry of Health, Spain). We also want to thank the private sponsors who support the basic and clinical projects of our institution (Piramal AG, Laboratorios Echevarne, Araclon Biotech S.A., and Fundació ACE). We are indebted to the Trinitat Port-Carbó legacy and her family for their support of Fundació ACE research programs. Fundació ACE is a participating center in the Dementia Genetics Spanish Consortium (DEGESCO). A.R. and M.B. receive support from the European Union/EFPIA Innovative Medicines Initiative Joint Undertaking ADAPTED and MOPEAD projects (Grants No. 115975 and 115985, respectively). M.B. and A.R. are also supported by national grants PI13/02434, PI16/01861, PI17/01474, and PI19/01301. Acción Estratégica en Salud is integrated into the Spanish National R + D + I Plan and funded by ISCIII (Instituto de Salud Carlos III)-Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER- “Una manera de Hacer Europa”). L.M.R. is supported by Consejería de Salud de la Junta de Andalucía (Grant PI-0001/2017). Control samples and data from patients included in this study were provided in part by the National DNA Bank Carlos III (www.bancoadn.org, University of Salamanca, Spain) and Hospital Universitario Virgen de Valme (Sevilla, Spain); they were processed following standard operating procedures with the appropriate approval of the ethical and scientific committees of these institutions. The present work was performed as part of the Biochemistry, Molecular Biology and Biomedicine doctoral program of S. Moreno-Grau at Universitat Autònoma de Barcelona (Barcelona, Spain). This work was supported by grants from the National Institutes of Health (R01AG044546, P01AG003991, RF1AG053303, R01AG058501, U01AG058922, RF1AG058501, and R01AG057777) and the Alzheimer’s Association (NIRG-11-200110, BAND-14-338165, AARG-16-441560, and BFG-15-362540). The recruitment and clinical characterization of research participants at Washington University were supported by NIH P50 AG05681, P01 AG03991, and P01 AG026276. This work was supported by access to equipment made possible by the Hope Center for Neurological Disorders, and the Departments of Neurology and Psychiatry at Washington University School of Medicine. For additional information about GR@ACE & DEGESCO consortia, please contact with aruiz@fundacioace.com The GR@ACE study group is composed by: Abdelnour C, Aguilera N, Alarcon E, Alegret M, Benaque A, Boada M, Buendia M, Cañabate P, Carracedo A, Corbatón A, de Rojas I, Diego S, Espinosa A, Gailhajenet A, García González P, Gil S, Guitart M, González Pérez A, Hernández I, Ibarria, M, Lafuente A, Macias J, Maroñas O, Martín E, Martínez MT, Marquié M, Mauleón A1, Monté-Rubio G, Montrreal L, Moreno-Grau S, Moreno M, Orellana A, Ortega G, Pancho A, Pelejà E, Pérez-Cordon A, Pineda JA, Preckler S, Quintela I, Real LM3,8, Rodríguez-Gómez O, Rosende-Roca M, Ruiz A, Ruiz S, Sáez ME, Sanabria A, Santos-Santos MA, Serrano-Rios M, Sotolongo-Grau O, Tárraga L, Valero S, Vargas L. The DEGESCO consortium is composed by: Adarmes-Gómez A.D, Alarcón-Martín E, Álvarez I, Álvarez V, Amer-Ferrer G, Antequera M, Antúnez C, Baquero M, Bernal M, Blesa R, Boada M, Buiza-Rueda D, Bullido M.J, Burguera J.A, Calero M, Carrillo F, Carrión-Claro M, Casajeros MJ, Clarimón J, Cruz-Gamero J.M, de Pancorbo MM, de Rojas I, del Ser T Diez-Fairen M, Fortea J, Franco E, Frank-García A, García-Alberca JM, Garcia Madrona S, Garcia-Ribas G, Gómez-Garre P, Hernández I, Hevilla S, Jesús S, Labrador Espinosa MA, Lage C, Legaz A, Lleó A, López de Munáin A, López-García S, Macias D, Manzanares S, Marín M, Marín-Muñoz J, Marín T, Marquié M, Martín Montes A, Martínez B, Martínez C, Martínez V, Martínez-Lage Álvarez P, Medina M, Mendioroz Iriarte M, Menéndez-González M, Mir P, Molinuevo J.L, Monté-Rubio G, Montrreal L, Moreno-Grau S, Orellana A, Pastor A.B, Pastor P, Pérez Tur J, Periñán-Tocino T Piñol Ripoll G, Rábano A, Real de Asúa D, Rodrigo S, Rodríguez-Rodríguez E, Royo J.L, Ruiz A, Sanchez del Valle Díaz R, Sánchez-Juan P, Sastre I, Sotolongo-Grau O, Tárraga L, Valero S, Vicente M.P, Vivancos L. Data collection and sharing for this project was partially funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging and the National Institute of Biomedical Imaging and Bioengineering, as well as through generous contributions from the following: AbbVie; the Alzheimer’s Association; the Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals | es_ES |
| dc.format.number | 1 | es_ES |
| dc.format.page | 142 | es_ES |
| dc.format.volume | 11 | es_ES |
| dc.identifier.citation | Transl Psychiatry . 2021 Feb 24;11(1):142 | es_ES |
| dc.identifier.doi | 10.1038/s41398-020-01145-1 | es_ES |
| dc.identifier.e-issn | 2158-3188 | es_ES |
| dc.identifier.journal | Translational psychiatry | es_ES |
| dc.identifier.pubmedID | 33627629 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/12684 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Springer | |
| dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2013) (2013)/PI13/02434 | |
| dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/Subprograma Estatal de Generación de Conocimiento/Proyectos de investigacion en salud (AES 2016). Modalidad proyectos en salud. (2016)/PI16/01861 | |
| dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/Subprograma Estatal de Generación de Conocimiento/PI17 - Proyectos de investigacion en salud (AES 2017). Modalidad proyectos en salud. (2017)/PI17/01474 | |
| dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I/Subprograma Estatal de Generación de Conocimiento/PI19 - Proyectos de investigacion en salud (AES 2019). Modalidad proyectos en salud. (2019)/PI19/01301 | |
| dc.relation.publisherversion | https://doi.org/10.1038/s41398-020-01145-1 | es_ES |
| dc.repisalud.centro | ISCIII::Servicios Centrales | es_ES |
| dc.repisalud.institucion | ISCIII | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.title | Long runs of homozygosity are associated with Alzheimer's disease. | es_ES |
| dc.type | research article | es_ES |
| dc.type.hasVersion | VoR | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 7b0177ec-7b89-4d97-813b-14c5ae64fc28 | |
| relation.isAuthorOfPublication.latestForDiscovery | 7b0177ec-7b89-4d97-813b-14c5ae64fc28 | |
| relation.isFunderOfPublication | d863b318-3e6b-4cfc-81bb-a6d112b1f86e | |
| relation.isFunderOfPublication | f04d23ec-a91d-4242-88b0-cc436888f8a2 | |
| relation.isFunderOfPublication | 7d739953-4b68-4675-b5bb-387a9ab74b66 | |
| relation.isFunderOfPublication | efa64f05-b985-4984-8f1e-5fc4ef21f502 | |
| relation.isFunderOfPublication | 4fbb4a31-6369-4e5d-8d27-b0de9829a963 | |
| relation.isFunderOfPublication | a4945b69-f49c-4fc3-aba2-2fa09e45a83f | |
| relation.isFunderOfPublication | b7f2086a-1682-47db-8088-78259ea3049b | |
| relation.isFunderOfPublication.latestForDiscovery | d863b318-3e6b-4cfc-81bb-a6d112b1f86e | |
| relation.isPublisherOfPublication | 8d558850-2ef2-4d1e-b0e1-4e5591ab6288 | |
| relation.isPublisherOfPublication.latestForDiscovery | 8d558850-2ef2-4d1e-b0e1-4e5591ab6288 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- LongRunsOfHomozygosity_2021.pdf
- Size:
- 2.69 MB
- Format:
- Adobe Portable Document Format
- Description:
Collections
Servicios Centrales
IBIS - Instituto de Biomedicina de Sevilla (Andalucía)
IdiPAZ - Instituto de Investigación Sanitaria Hospital La Paz (Madrid)
IDIS - Instituto de Investigación Sanitaria de Santiago de Compostela (Galicia)
IDIVAL - Instituto de Investigación Marqués de Valdecilla (Cantabria)
IR Sant Pau - Instituto de Investigación Sant Pau (Cataluña)
Load more IBIS - Instituto de Biomedicina de Sevilla (Andalucía)
IdiPAZ - Instituto de Investigación Sanitaria Hospital La Paz (Madrid)
IDIS - Instituto de Investigación Sanitaria de Santiago de Compostela (Galicia)
IDIVAL - Instituto de Investigación Marqués de Valdecilla (Cantabria)
IR Sant Pau - Instituto de Investigación Sant Pau (Cataluña)


